1·They received either lamotrigine in an extended-release formula or placebo for 19 weeks.
他们得到的要么拉莫三嗪，在延长释放配方或安慰剂，为19周。
2·Objective: To explore the efficacy and safety of lamotrigine in the treatment of bipolar mood disorder.
目的：探讨拉莫三嗪治疗双相情感障碍的疗效与安全性。
3·To verify the curative effect and safety of lamotrigine (LTG) for the treatment of childhood epilepsy, a open-label, add-on, self-control study was undertaken on 44 children with intractable epilepsy.
为验证拉莫三嗪治疗儿童癫痫的疗效和安全性，对44例儿童顽固性癫痫进行了开放性自身对照研究。
4·The article reviews the recent progress in research on the neuroprotective effect and its mechanism of lamotrigine in cerebral ischemia.
文章就近年来拉莫三嗪对脑缺血的神经保护作用及其机制的研究进展做了综述。
5·Lamotrigine (in both formulations) can also cause other types of allergic reactions or serious problems that may affect parts of the body such as the liver or blood cells.
拉莫三嗪(两种剂型)也会导致其他类型的过敏反应或严重问题。它们可能影响身体健康，比如肝或血细胞。